Adalimumab versus Conventional Immunosuppression for Uveitis (ADVISE) Trial. [PDF]
OphthalmologyAdalimumab versus Conventional Immunosuppression for Uveitis Trial Research Group +10 more
europepmc +1 more source
Antimeningococcal Protection in Patients Receiving Terminal Complement Inhibitors. [PDF]
Kidney Int RepVujović A +10 more
europepmc +1 more source
Comparative Analysis of Chemotherapy Resistance Mechanisms in Humans and Companion Animals. [PDF]
Vet SciCravo DLM +7 more
europepmc +1 more source
Systematic Review of Immunosuppression After Chimeric Antigen Receptor T-Cell Therapy for Posttransplant Lymphoproliferative Disorder. [PDF]
Kidney Int RepSynnott D, Bowden A, Sexton DJ.
europepmc +1 more source
Coronary artery disease and cancer: Shared risk factors, pathogenesis, and treatment effects. [PDF]
Am Heart J PlusCharbel N +3 more
europepmc +1 more source
Tocilizumab as an effective treatment option for idiopathic orbital inflammation: a case report and literature review. [PDF]
Int J OphthalmolZhang HY, Zhang HJ, Zhou HF.
europepmc +1 more source
Mismatch Between Preclinical Cardio-Oncology and Clinical Oncology Research. [PDF]
JACC CardioOncolCagnazzo R +6 more
europepmc +1 more source
Trends in the Dispensing of Oral Anti-Cancer Medications Across Australia Over 10 Years. [PDF]
Pharmacoepidemiol Drug SafLeach MJ +5 more
europepmc +1 more source
Understanding Chemotherapy-Induced Thrombocytopenia: Implications for Gastrointestinal Cancer Treatment. [PDF]
Curr OncolPeshin S +5 more
europepmc +1 more source